Kourzeq

Drug overview for KOURZEQ (triamcinolone acetonide):

Generic name: triamcinolone acetonide (tri-am-SIN-oh-lone)
Drug class: Steroids - Mouth
Therapeutic class: Mouth-Throat-Dental - Preparations

Triamcinolone acetonide is a synthetic fluorinated corticosteroid.

Triamcinolone shares the actions of the other topical corticosteroids and is used for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses. The drug is also used as a paste for adjunctive treatment to provide temporary relief of symptoms associated with oral inflammatory or ulcerative lesions resulting from trauma.

DRUG IMAGES

KOURZEQ 0.1% DENTAL PASTE

The following indications for KOURZEQ (triamcinolone acetonide) have been approved by the FDA:

Indications:
Stomatitis

Professional Synonyms:
Inflammation of the mouth
Inflammatory disease of mucous membrane
Mucositis

The following dosing information is available for KOURZEQ (triamcinolone acetonide):

Dosing
Administration
KOURZEQ
TRIAMCINOLONE ACETONIDE

Dermatologic preparations of triamcinolone acetonide are applied sparingly in thin films and are rubbed gently into the affected area 2-4 times daily. The 0.5% cream and 0.5%

ointment should be used only in the treatment of dermatoses which are refractory to treatment with lower concentrations. The 0.1 and 0.5%

creams are applied 2-3 times daily according to severity of the condition. When the aerosol is applied, an area about the size of the patient's hand is sprayed for about 2 seconds from a distance of about 7.5-15 cm 3 or 4 times daily.

Occlusive dressings may be used for severe or resistant dermatoses.

For use in the mouth, a small amount (about 0.6 cm) of the 0.1% paste is pressed to the lesion without rubbing until a thin film develops; a larger amount may be required to cover some lesions. The paste is applied at bedtime and, if necessary, 2 or 3 times daily, preferably after meals. If substantial regeneration or repair of the oral tissues does not occur after 7 days of treatment, further investigation of the etiology of the oral lesions should be undertaken.

No enhanced Administration information available for this drug.

Dosing information for KOURZEQ
DRUG LABEL	DOSING TYPE	DOSING INSTRUCTIONS
KOURZEQ 0.1% DENTAL PASTE	Maintenance	Adults place a small amount to the affected area by mucous membrane route 2-3 times daily after meals

Generic dosing information for TRIAMCINOLONE ACETONIDE
DRUG LABEL	DOSING TYPE	DOSING INSTRUCTIONS
TRIAMCINOLONE 0.1% PASTE	Maintenance	Adults place a small amount to the affected area by mucous membrane route 2-3 times daily after meals

Contraindication List
Acute oral cavity infection
Oral candidiasis

Moderate List
Hypothalamic-pituitary insufficiency

The following adverse reaction information is available for KOURZEQ (triamcinolone acetonide):

Overview
Severe
Less Severe

Adverse reaction overview.

No enhanced Common Adverse Effects information available for this drug.

There are 3 severe adverse reactions.

More Frequent	Less Frequent
None.	None.

Rare/Very Rare
Hyperglycemia Mouth irritation Peptic ulcer

There are 1 less severe adverse reactions.

More Frequent	Less Frequent
None.	None.

Rare/Very Rare
Dysgeusia

The following precautions are available for KOURZEQ (triamcinolone acetonide):

Pediatric
Pregnant
Lactation
Geriatric

No enhanced Pediatric Use information available for this drug.

Contraindicated

None

Severe Precaution

None

Management or Monitoring Precaution

None

No enhanced Pregnancy information available for this drug.

No enhanced Lactation information available for this drug.

No enhanced Geriatric Use information available for this drug.

Stomatitis
K12.0	Recurrent oral aphthae
K12.1	Other forms of stomatitis
K12.3	Oral mucositis (ulcerative)
K12.30	Oral mucositis (ulcerative), unspecified
K12.31	Oral mucositis (ulcerative) due to antineoplastic therapy
K12.32	Oral mucositis (ulcerative) due to other drugs
K12.33	Oral mucositis (ulcerative) due to radiation
K12.39	Other oral mucositis (ulcerative)